| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.37▲ | 9.40▲ | 9.42▲ | 8.71▲ | 8.78▲ |
| MA10 | 9.37▲ | 9.42▲ | 9.25▲ | 8.89▲ | 8.06▲ |
| MA20 | 9.36▲ | 9.24▲ | 8.97▲ | 8.67▲ | 7.49▲ |
| MA50 | 9.41▲ | 8.81▲ | 8.76▲ | 7.80▲ | 8.37▲ |
| MA100 | 9.28▲ | 8.77▲ | 9.21▲ | 7.35▲ | 11.45▼ |
| MA200 | 9.00▲ | 9.16▲ | 8.31▲ | 7.57▲ | 13.46▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.007▲ | -0.011▼ | 0.059▲ | -0.053▼ | 0.353▲ |
| RSI | 56.521▲ | 64.436▲ | 67.690▲ | 61.427▲ | 59.837▲ |
| STOCH | 55.172 | 49.991 | 67.463 | 18.880▼ | 58.365 |
| WILL %R | -6.897▲ | -34.574 | -24.715▲ | -53.650 | -34.711 |
| CCI | 135.839▲ | 17.438 | 62.655 | 19.866 | 129.817▲ |
|
Monday, November 24, 2025 05:19 AM
Updated data expands clinically meaningful results available from FIREFLY-1 pivotal trial 77% of patients who entered the treatment-free observation period following OJEMDA treatment remained off ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/11/25 | 9.08 | 9.765 | 8.91 | 9.43 | 2,819,335 |
| 24/11/25 | 8.51 | 9.11 | 8.42 | 8.88 | 3,833,352 |
| 21/11/25 | 8.31 | 8.70 | 8.16 | 8.52 | 2,930,142 |
| 20/11/25 | 8.57 | 8.73 | 8.22 | 8.29 | 1,964,069 |
| 19/11/25 | 8.522 | 8.76 | 8.355 | 8.41 | 2,213,807 |
| 18/11/25 | 8.84 | 9.08 | 8.545 | 8.57 | 1,531,766 |
| 17/11/25 | 8.81 | 9.395 | 8.54 | 8.84 | 3,333,244 |
| 14/11/25 | 8.77 | 9.05 | 8.56 | 8.80 | 3,549,485 |
| 13/11/25 | 9.00 | 10.187 | 8.71 | 8.85 | 5,138,720 |
| 12/11/25 | 10.36 | 10.4499 | 10.03 | 10.34 | 2,548,835 |
|
|
||||
|
|
||||
|
|